SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $663,000 | -11.2% | 920,995 | +146.5% | 0.25% | -18.9% |
| Q3 2018 | $747,000 | -5.7% | 373,702 | 0.0% | 0.31% | -17.3% |
| Q2 2018 | $792,000 | -22.0% | 373,702 | 0.0% | 0.37% | -24.9% |
| Q1 2018 | $1,016,000 | -64.8% | 373,702 | -52.3% | 0.49% | -68.3% |
| Q4 2017 | $2,889,000 | +79.1% | 783,000 | -5.8% | 1.56% | +55.3% |
| Q3 2017 | $1,613,000 | -29.7% | 831,332 | -2.2% | 1.00% | -38.8% |
| Q2 2017 | $2,296,000 | -35.5% | 850,328 | -2.0% | 1.64% | -45.6% |
| Q1 2017 | $3,557,000 | -13.3% | 867,529 | -23.5% | 3.01% | -16.6% |
| Q4 2016 | $4,104,000 | – | 1,133,583 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 7,600,000 | $9,234,000 | 7.03% |
| Samsara BioCapital, LLC | 3,750,000 | $4,556,000 | 3.58% |
| CAXTON CORP | 277,245 | $337,000 | 0.31% |
| BVF INC/IL | 2,287,860 | $2,780,000 | 0.31% |
| Eventide Asset Management | 5,965,455 | $7,248,000 | 0.25% |
| Telemetry Investments, L.L.C. | 197,564 | $240,000 | 0.12% |
| NEA Management Company, LLC | 1,298,274 | $1,584,000 | 0.08% |
| RP Management, LLC | 129,517 | $158,000 | 0.08% |
| Palo Alto Investors LP | 1,162,473 | $1,412,000 | 0.06% |
| Fosun International Ltd | 725,000 | $863,000 | 0.06% |